Shenzhen Xinhe Biomedical
Shenzhen Xinhe Biomedical
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| To Evaluate the Safety, Tolerability, and Preliminary Efficacy of XH001 Injection as Adjuvant Therapy in Patients With High-risk Recurrent Solid Tumors | Biliary Tract Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, biliary tract disorder, carcinoma, cholangiocarcinoma, digestive system disorder, digestive system neoplasm, epithelial neoplasm, gallbladder disorder, gallbladder neoplasm, gastric neoplasm, hepatocellular carcinoma, liver disorder, neoplasm, stomach disorder | Recruiting | Phase 1 | 2026-05-19 | NCT07594964 |